Clinical Trial

Coronary Sinus Reducer For The Management Of Symptomatic Heart Failure

Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
The purpose of this study is to evaluate the efficacy of CS Reducer implantation in patients with HFpEF and CMD on left ventricular filling pressures, specifically invasive measurement of PAWP during standardized exercise.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2025-06-30; most recent amendment 2026-03-18.
Status change: Recruiting → Enrolling by Invitation 2025-11-13
Status change: Not Yet Recruiting → Recruiting 2025-09-09
Trial Details
NCT Number NCT07057323
Lead Sponsor Mayo Clinic
Collaborators: Shockwave Medical, Inc.
Conditions Heart Failure Preserved Ejection Fraction
Enrollment 35 participants
Start Date 2025-10-16
Primary Completion 2027-08 (estimated)
Study Completion 2027-08 (estimated)
Updated on ClinicalTrials.gov 2026-08-05